Chembio Diagnostics Reports Third Quarter 2022 Financial Results

Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today

Related Keywords

United States ,Malaysia ,United Kingdom ,Brazil ,Richard Eberly ,Philip Taylor ,Company Nasdaq ,Reszon Diagnostics International ,Global Competitiveness Program ,Antigen Panel ,Exchange Commission ,Chembio Diagnostics Inc ,Gilmartin Group ,Dual Path Platform ,Syphilis Treponemal Nontreponemal ,Sure Check ,Chembio Malaysia ,Chief Executive ,Investor Relations ,Global Competitiveness ,Private Securities Litigation Reform Act ,Detect Self Test ,Annual Report ,Quarterly Reports ,Chembio ,Diagnostics ,Reports ,Third ,Quarter ,2022 ,Financial ,Results ,